Paclitaxel is drug used for treatment of cancers of progress breast cancer other kinds. Paclitaxel is compound extracted from the bark of Pacific Yew tree. FDA approved use of Paclitaxel for treatment and following clinical trials demonstrated its effectiveness. It contains cancer-fighting properties that aid in killing tumor cells. Side effects of Paclitaxel are found in very rare cases, and can range from light to intense.
Paclitaxel works good for Ovarian Cancer. Paclitaxel can be used as a complementary or first-line treatment for ovarian cancer. It’s used in combination with other complementary medicine called cisplatin. It’s found to be effective in metastasised instances, as well as those cases which have become resistant to treatment. According to Phase II clinical trials, patients taking Paclitaxel demonstrated 25 percent response rate. More recently a study published in the Lancet(15) affirmed the important value of Paclitaxel in relapsed advanced ovarian cancer. Cancer cells stop from growing by changing cell structures called microtubules, which are important in cell functions.
Paclitaxel prolong survival in Lung Cancer patients. Studies have found the favorable effects of Paclitaxel on non small cell lung cancer, which isn’t likely to be cured by surgery or radiation. Month paclitaxel is well known to prolong survival by two. Lung cancer patients outnumber patients of Breast and Ovarian Cancer combined. It was likewise concluded that weekly dose of Paclitaxel is effective in improving symptoms of other kind of cancer.
Paclitaxel Offers treatment for Breast Cancer. Paclitaxel is quite effective in treating HER positive breast cancer, that is more aggressive disorder. It is licensed to take care of instances of node positive breast carcinoma that was early. It is well known to enhance survival chances. Studies demonstrate patients treated with Paclitaxel endure longer than those treated with standard combination, which is well tolerated by patients. It has additionally been found to be effective in relapse cases of breast cancer which have been treated with chemotherapy.
The instances of advanced Kaposi’s sarcoma that are not reacting to liposomal anthracycline chemotherapy, Paclitaxel can be used to alleviate the outward symptoms. According to a study done on 17 patients with AIDS-associated KS, the reaction rate of 71 percent was discovered. More research is needed to get the actions of Paclitaxel in immune compromised patients in cases of advanced Kaposi’s sarcoma. Studies are still going on to find the favorable effects of Paclitaxel on additional kinds of cancer cells.
This chemotherapeutic drug is associated with several side effects. A few of these contain pain in muscles and joints, decline in the number of healthy white blood cells and red blood cells, bleeding, increased susceptibility to infections, hair loss, alopecia, allergic reaction to mental confusion, low blood pressure and medicine. Nursing and pregnant women should avoid taking this medication. Those taking medications for existing health conditions should consult with their healthcare provider prior to taking this medication.